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ABSTRACT
Retinoic acid-related orphan receptors (RORs) and
the basic helix–loop–helix-PAS transcription factor
Npas2 have been implicated in the control of circa-
dian rhythm. In this study, we demonstrate that
RORc directly regulates Npas2 expression in vivo.
Although the rhythmicity of Npas2 mRNA expression
was maintained in RORc
/ mice, the peak level
of expression was significantly reduced in several
tissues, while loss of RORa had little effect.
Inversely, overexpression of RORc in hepatoma
Hepa1-6 cells greatly induced the expression of
Npas2. RORc-activated Npas2 transcription directly
by binding two ROREs in its proximal promoter.
ChIP analysis demonstrated that RORc was
recruited to this promoter in the liver of wild-type
mice, but not RORc-deficient mice. Activation of
Npas2 correlated positively with chromatin acces-
sibility and level of H3K9 acetylation. The activation
of Npas2 by RORc was repressed by co-expression
with Rev-Erba or addition of the ROR inverse
agonist T0901317. Npas2 expression was also
significantly enhanced during brown adipose differ-
entiation and that this induction was greatly sup-
pressed in adipose cells lacking RORc. Our results
indicate that RORc and Rev-Erba are part of a
feed-back loop that regulates the circadian expres-
sion of Npas2 suggesting a regulatory role for
these receptors in Npas2-dependent physiological
processes.
INTRODUCTION
The retinoic acid-related orphan receptor (ROR) subgroup
of nuclear receptors consists of three members, RORa,- b
and -g (NR1F1-3 or RORA-C) (1). As a result of
alternative promoter usage and/or exon splicing each
ROR gene generates several isoforms that differ only in
their amino terminus. These variants exhibit a distinct
pattern of tissue-speciﬁc expression and are involved in
the regulation of different physiological processes and
target genes. The RORs bind as a monomer to ROR
response elements (ROREs) in the promoter regulatory
region of target genes (2,3). Transcriptional regulation by
RORs is mediated by the recruitment of co-repressor and
co-activator complexes which, through their his-
tone(de)acetylase activities, induce changes in chromatin
conformation (1,4). Recent studies have demonstrated
that RORs function as ligand-dependent transcription
factors. All-trans retinoic acid and several other retinoids
act as partial antagonists of RORb and T0901317 and
7a-hydroxycholesterol as inverse agonists of RORa and
RORg, while cholesterol sulfate has been reported to
function as an RORa agonist (5–8).
RORs regulate several important physiological
processes and have been implicated in a number of
pathologies (1). RORa is critical for cerebellar develop-
ment and bone formation (9,10), while RORb regulates
functions in the brain and retina (11,12). RORg plays a
key role in lymph node development and thymopoiesis
(13,14). Furthermore, both RORa and RORg are
involved in regulating various metabolic pathways, in-
ﬂammatory responses and immune functions, including
Th17 cell differentiation (1,15–19).
In addition to these functions, all three RORs have been
implicated in the regulation of various aspects of circadian
rhythm (1,11,20–27). Circadian rhythm is fundamental in
the regulation of a wide variety of physiological and
behavioral activities. In mammals, the central clock in
the suprachiasmatic nucleus (SCN) integrates light–dark
cycle input and synchronizes the autonomous oscillators
in peripheral tissues (28–30). The molecular basis of the
circadian clock involves interlocking transcriptional/
translational feedback loops that regulate the rhythmic
expression and activity of a set of core clock genes,
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domain-type transcriptional activators brain and muscle
aryl hydrocarbon receptor nuclear translocator
(ARNT)-like (Bmal1), circadian locomotor output cycles
kaput (Clock), two cryptochrome (Cry) and three period
(Per) proteins. The positive loop consists of the basic
helix–loop–helix/PAS-type transcription activators
Bmal1 and Clock, while Cry and Per are involved in the
negative control of the oscillator (31–36). The repression
of Bmal1 is mediated by the nuclear orphan receptors
Rev-ErbAa and Rev-Erbb, which function as transcrip-
tional repressors, while RORs have been implicated in
the positive regulation of several clock genes, including
Bmal1 and Rev-Erb  (1,22–24,26,37,38). The circadian
clock subsequently regulates the rhythmic expression of
downstream genes involved in timing the rhythmic regu-
lation of numerous functions, including behavior, repro-
ductive and neuroendocrine functions, and metabolism.
In this study, we identify neuronal PAS domain protein
2 (Npas2), a paralogs of Clock, as a new ROR target gene.
Npas2 heterodimerizes with Bmal1 and regulates the tran-
scription of circadian genes (39–41). Npas2 and Clock
have been reported to exhibit overlapping functions.
Single nucleotide polymorphisms (SNPs) in Npas2 have
been linked to increased risk of cancer, unipolar major
depression, metabolic syndrome and hypertension (42–
47). In this study, we demonstrate that the loss of particu-
larly RORg signiﬁcantly reduced the peak level of Npas2
mRNA expression in several tissues without affecting the
rhythmicity of Npas2 expression. We further show that
RORg regulates Npas2 transcription directly through
two ROREs in its proximal promoter. This activation is
inhibited by the inverse RORg agonist T0901317 and
by Rev-Erba. Collectively, these data indicate that both
RORg and Rev-Erba are part of the mechanism that regu-
lates the oscillatory expression of Npas2 and suggest a
regulatory role for these receptors in Npas2-dependent
physiological processes and pathologies, including circa-




Heterozygous C57BL/6 staggerer (ROR 
+/sg) mice were
purchased from Jackson Laboratories (Bar Harbor, ME,
USA). The generation and initial characterization of
C57BL/6 ROR 
/ mice were described earlier (13).
Mice were supplied ad libitum with NIH-A31 formula
and water as described earlier (16) and maintained at
25C on a constant 12h light:12h dark cycle. Littermate
wild-type (WT) mice were used as controls for both
ROR-deﬁcient models. For cold-induced thermogenesis
mice were placed at 4C for 4h. All animal protocols
followed the guidelines outlined by the NIH Guide for
the Care and Use of Laboratory Animals and were
approved by the Institutional Animal Care and Use
Committee at the NIEHS.
RNA isolation
To study gene expression during circadian time, tissues
were excised from WT, ROR 
/, and ROR 
sg/sg mice
every 4h over a period of 24h, processed overnight in
RNAlater solution (Ambion, Austin, TX, USA) at
4C, and then stored at 80C until use. Tissues were
then homogenized in RLT buffer (Qiagen, Valencia, CA,
USA) with a Polytron PT-3000 (Brinkmann Instruments,
Westbury, NY, USA). RNA was then extracted using a
QIAshredder column and RNeasy Mini kit (Qiagen) ac-
cording to the manufacturer’s instructions. Hepa1-6 cells
and brown adipocytes were lysed in lysis (RLT) buffer and
RNA extracted as described for tissues. The brown adipo-
cytes were treated for 24h (from differentiation Day 4 to
5) with and without 10mM of the inverse ROR agonist
T0901317 (7) (Sigma-Aldrich, St Louis, MO, USA) before
RNA extraction.
Quantitative reverse transcription-polymerase chain
reaction (QRT-PCR) analysis
QRT-PCR analysis was performed using SYBR Green I
or TaqMan system (Applied Biosystems, Foster City, CA,
USA) to quantify gene expression. All primer and probe
sequences are listed in Supplementary Table S1. The RNA
was reverse-transcribed using a High-Capacity cDNA
Archive Kit (Applied Biosystems). The reactions were
carried out in triplicate using 20ng of cDNA and the fol-
lowing conditions: 2min at 45C and 10min at 95C,
followed by 40 cycles of 15s at 95C and 60s at 60C.
All the results were normalized by the amount of 18S
rRNA or Gapdh mRNA.
Isolation of brown preadipocytes
Brown fat preadipocytes were isolated from postnatal
day 2 (PND2) WT and ROR 
/ brown adipose tissue
by collagenase digestion as described earlier (48).
Preadipocytes were immortalized by infection with pBabe
retrovirus encoding SV40-Large T antigen. After selection
with puromycin (2mg/ml), resistant clones were isolated.
Several clones of the each genotype, WT, ROR 
+/ and
ROR 
/ were obtained. Cells were grown in DMEM
supplemented with 10% fetal bovine serum (FBS), 1nM
thyroid hormone (T3) and 20nM insulin (differentiation
medium). Differentiation in conﬂuent cultures was
induced by the addition of 1mM dexamethasone,
0.125mM indomethacin and 0.5mM isobutylmethyl-
xanthine. After 2 days incubation, the medium was
changed to the normal differentiation medium and
replaced every other day as described earlier (49).
Hepa1-6 and brown preadipocyte stable cell lines
Hepa1-6 cell lines stably expressing Flag-RORa4,
Flag-RORg1 and Flag-Rev-Erba were generated after
transfection with the respective pLXIN plasmid DNA
and subsequent selection in G418 (Clontech, Palo Alto,
CA, USA). In the remaining of the article, RORa4 and
RORg1 are commonly referred to as RORa and RORg.
Brown adipocyte cell lines BAT(E), BAT(RORg) and
BAT(RORgE502Q) stably expressing empty vector,
4770 Nucleic Acids Research, 2011,Vol.39, No. 11RORg or the RORgE502Q mutant containing an inactive
activation domain, respectively, were generated in the
same way from immortalized preadipocytes. The expres-
sion and nuclear localization of RORg protein were con-
ﬁrmed by western blot analysis and immunochemical
staining, respectively. Cell lines established from ﬁve indi-
vidual clones were examined in QRT-PCR and chromatin
immunoprecipitation (ChIP) analysis.
ChIP assay
ChIP assay was performed using a ChIP assay kit from
Millipore (Billerica, MA, USA) according to the manufac-
turer’s protocol with a few minor modiﬁcations. Brieﬂy,
the livers isolated from WT, ROR 
sg/sg and ROR 
/
mice were homogenized with a polytron PT 3000
(Brinkmann Instruments) and cross-linked by 1% formal-
dehyde for 20min at room temperature. After a wash in
PBS, an aliquot of the cross-linked chromatin was
sonicated and incubated overnight with anti-RORa or
anti-RORg antibody (sc-6062 sc-28559, respectively;
Santa Cruz Biotechnology, Santa Cruz, CA, USA). To
analyze histone H3 lysine 9 (H3K9) acetylation within
the Npas2 promoter region, ChIP assays were performed
with an anti-H3K9Ac antibody (ab4441; Abcam,
Cambridge, MA, USA). After incubation with protein G
agarose beads for 2h, and several washes, DNA–protein
complexes were eluted. The cross-links were reversed by
overnight incubation at 65C in the presence of 25mM
NaCl and subsequent digestion with RNase A and pro-
teinase K, followed by puriﬁcation of the chiped-DNA.
The fold amount of the chiped-DNA relative to each
input DNA was determined by QPCR. All QPCR reac-
tions were carried out in triplicate. The procedure for
ChIP analysis using Hepa1-6 cells or brown adipocytes
was similar as described for tissues except that 210
6
cells were cross-linked with 4% formaldehyde for 10min
and the immunoprecipitation was performed with
anti-Flag M2 afﬁnity gel (Sigma-Aldrich). The sequences
of the primers used for ChIP-QPCR are listed in
Supplementary Table S1.
Formaldehyde-assisted isolation of regulatory elements
Formaldehyde-assisted isolation of regulatory elements
(FAIRE) was performed as described earlier (50).
Brieﬂy, mouse livers were cross-linked and sonicated as
described for the ChIP assay. Samples were centrifuged
and the DNA in the supernatants isolated by three con-
secutive extractions with phenol–chloroform–isoamyl
alcohol (25:24:1). After the ﬁnal extraction, the FAIRE
samples were reverse-cross-linked as described for the
ChIP assay. The enrichment of fragmented genomic
DNA in the FAIRE samples relative to each input
DNA was measured in triplicate by QPCR.
Reporter gene assay
To generate pGL4.10-Npas2(–1534/+81), the region of
1534/+81bp of the murine Npas2 promoter was cloned
into the promoter-less reporter plasmid pGL4.10
(Promega, Madison, WI, USA). The mutant pGL4.10-
Npas2(–1534/+81) plasmids, in which one of the two
ROREs or both ROREs were mutated from AGGTCA
to AAATCA, were generated using a Quickchange site-
directed mutagenesis kit (Stratagene, La Jolla, CA, USA).
The sequences were veriﬁed by DNA sequencing. Huh-7
and HEK293T cells were co-transfected with pGL4.10-
Npas2(–1534/+81), pGL4.10, or pCMVb-Gal reporter
plasmids and p3xFlag-CMV10-RORg, p3xFlag-CMV10-
RORa or p3xFlag-CMV10-Rev-Erba expression plasmids
as indicated using Lipofectamine 2000 (Invitrogen,
Carlsbad, CA, USA). After 24h incubation, the luciferase
and b-galactosidase activities were measured by Luciferase
Assay Substrate (Promega) and Luminescent b-galacto-
sidase Detection Kit II (Clontech). All transfections were
performed in triplicate, and each experiment was repeated
at least twice.
RESULTS
Regulation of circadian expression of Npas2 by RORs
Several studies have provided evidence for a role of RORs
in the regulation of several circadian clock genes
(1,11,20,23,24,26,27,38). In this study, we focused on the
regulation of Npas2 by RORa and RORg. First, we
analyzed the effect of the loss of RORa or RORg expres-
sion on the circadian expression of Npas2 in the liver,
brown adipose tissue (BAT), kidney and small intestines
using ROR 
sg/sg and ROR 
/mice. Consistent with a
previous report, Npas2 mRNA showed a strong oscilla-
tory pattern of expression in the liver of WT mice with
peak expression between CT20 and CT0 and a low point
at CT12 (Figure 1A and B) (51). However, the oscillatory
expression of Npas2 was signiﬁcantly altered in ROR 
/
liver. At CT0, when Npas2 is highly expressed in WT liver,
expression of Npas2 mRNA was reduced by about 60% in
the liver of ROR 
/ mice (Figure 1A). Npas2 expression
exhibited a similar robust oscillatory pattern in BAT,
kidney, small intestines and white adipose tissue (WAT)
as in WT liver (Figure 1C–H). However, between CT20
and CT4 Npas2 expression was greatly decreased in BAT
of ROR 
/ mice (Figure 1C), reduced modestly in
ROR 
/ kidney (Figure 1E) and was slightly enhanced
in the small intestines (Figure 1G). Little change was
observed in the pattern of Npas2 expression in the liver
and WAT from ROR 
sg/sg mice (Figure 1B and H), while
a small shift in peak Npas2 expression was seen in
ROR 
sg/sg kidney (Figure 1F) and an increase in
ROR 
sg/sg BAT. RORa is not expressed in small
intestines.
Earlier studies identiﬁed a certain degree of redundancy
between the regulation of gene expression by RORa and
RORg (16). To examine whether there was any func-
tional redundancy between RORa and RORg, Npas2
expression was examined in ROR 
sg/sgROR 
/ double
knockout (DKO) mice. As shown in Figure 1I, at CT20
Npas2 expression was reduced to a very similar degree in
the liver, BAT and kidney of DKO mice as observed in
ROR 
/ mice. Together, these results indicate that the
circadian expression of Npas2 is largely regulated by
RORg and to a minor extent by RORa and that this regu-
lation exhibits a certain tissue speciﬁcity.
Nucleic Acids Research, 2011,Vol.39, No. 11 4771Figure 1. Comparison of the circadian expression of Npas2 in several peripheral tissues from WT, ROR 
-/– and ROR 
sg/sg mice. (A–H) Various
tissues from WT, ROR 
/ and ROR 
sg/sg mice (n=4) were isolated every 4h over a period of 24h and expression of Npas2 was analyzed by
QRT-PCR. The 24-h expression pattern was double plotted. (I) Tissues were isolated from ROR 
/, ROR 
sg/sgROR 
/ DKO mice (n =4 )a t
CT20. Npas2 expression in DKO and RORg
/ mice was normalized to the expression in littermate WT mice. (J) Circadian pattern of ROR 1,
ROR 1 and ROR 4 mRNA expression in liver from WT, ROR 
/ and ROR 
sg/sg mice and Rev-Erb  expression in WT mice (n=4). Data present
mean±SD, *P<0.05, **P<0.01, ***P<0.001 by ANOVA.
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of Npas2 in liver to those of RORa and RORg,w e
examined their circadian pattern of expression. Figure 1J
shows that particularly ROR 1, the only RORg isoform
expressed in liver, showed a robust oscillatory pattern of
expression, while ROR 1, which is expressed at low levels,
has a moderate and ROR 4, which in liver is the predom-
inant a isoform, exhibited a weak oscillatory pattern con-
sistent with earlier observations (16,20,52). Loss of RORg
or RORa expression had little effect on the circadian ex-
pression of ROR 1 or  4 and ROR 1 mRNA, respective-
ly, suggesting that ROR  and ROR  are regulated
independently from each other (Figure 1J). The phase of
the oscillatory expression of ROR 1 in liver (zenith at
CT18) was slightly earlier than that of Npas2 (zenith at
CT20) and the opposite of that of ROR 1 and Rev-Erb 
expression (zenith at CT8) (Figure 1J).




Npas2 and Clock are paralogues that share several func-
tions (39–41). Each protein can form a heterodimer with
Bmal1. Moreover, Npas2 is able to functionally substitute
for Clock in the master clock in the SCN and overlapping
functions have been reported in the liver. A putative
RORE has been identiﬁed in the human and mouse
promoter region of the Clock gene, while EMSA
analysis showed that RORs were able to bind to this
RORE (27). To further examine the potential role of
RORs in the regulation of Clock, we next determined
the effect of the loss of RORa or RORg on its expression.
In the liver, BAT, kidney and intestines Clock exhibited a
less-robust oscillatory pattern of expression than Npas2
with maximum expression around CT0 and a similar
circadian phase as Npas2 (Supplementary Figure S1).
No signiﬁcant differences in the circadian expression
pattern of Clock were observed in the liver, BAT and
WAT between WT and ROR 
sg/sg or ROR 
/ mice
(Supplementary Figure S1A–D and H). Interestingly, at
CT20 and CT0 Clock expression was greatly down-
regulated in the kidney of ROR 
sg/sg mice compared
with WT kidneys (Supplementary Figure S1F), while
loss of RORg signiﬁcantly reduced the amplitude of the
oscillatory expression of Clock in kidney (Supplementary
Figure S1E). Moreover, Clock expression was signiﬁcantly
reduced (by about 25%) at CT0 and CT4 in the small
intestines of ROR 
/ mice compared with WT controls
(Supplementary Figure S1G). These results indicate that
the regulation of Clock expression by RORs is tissue
dependent and less stringent than that of Npas2.
Examination of Clock expression in DKO mice showed
that in contrast to single KO mice Clock expression was
signiﬁcantly reduced in the liver and BAT of DKO mice
(Supplementary Figure S1I).
Activation and in vivo ROR binding to the
Npas2 promoter
RORs bind as a monomer to ROREs consisting of the
consensus sequence AGGTCA preceded by a 6-bp A/T
rich region, in the promoter regulatory region of target
genes (1–3). The murine Npas2 proximal promoter
region contains 2 successive putative ROREs at 1372
and 1399 that are spanned by 21bp (Figure 2A). These
ROREs are conserved between mouse and human Npas2.
Although EMSA showed that RORs can bind these
ROREs (27), the functionality of these ROREs in the
intact promoter and whether RORs are recruited to this
Npas2 promoter region in vivo have not been studied. To
examine whether RORs were able to activate the Npas2
proximal promoter, reporter gene assays were performed
in human hepatoma Huh-7 cells and human kidney epi-
thelial HEK293T cells with a pGL4.10-Npas2(–1534/+81)
reporter plasmid in which the Luc reporter was placed
under the control of the 1534/+81 proximal promoter
region of Npas2. Figure 2B shows that in Huh-7 cells
RORg was able to activate the Npas2 promoter more
than 20-fold compared with transfection with the
p3xFlag-CMV10 empty vector. Expression of RORa
also greatly increased the activation of the Npas2(–1534/
+81) promoter. To determine which of the two sites was
important in this activation, the effect of AGGTCA to A
AATCA mutations in the RORE1 and RORE2 on the
activation of the Npas2 promoter was examined.
Mutation of RORE1 modestly reduced the activation of
the Npas2 promoter by either RORa or RORg and
mutation of the RORE2 decreased the activation more
than the RORE1 mutation. Mutation of both ROREs
almost completely abolished the activation of the
Npas2(–1534/+81) promoter by RORs. Similar results as
for Huh-7 were obtained in HEK293T cells (Figure 2C).
During submission of this manuscript a different study
provided evidence for a role of another RORE-like site
(RORE3) at 1207 of the mouse Npas2 promoter in its
activation by RORa (53). However, mutation of this
RORE within the Npas2(–1534/+81) promoter had little
effect on its activation by RORa or RORg and did not
affect its repression by Rev-Erba, suggesting that this site
plays a minor role in the regulation of Npas2 by these
receptors (Supplementary Figure S2). Our observations
indicate that RORE1 and RORE2, rather than RORE3,
contributed to the activation of the Npas2(–1534/+81)
promoter by RORa and RORg, with a more prominent
role for RORE2 than RORE1.
Inhibition of Npas2(–1534/+81) promoter activation by
Rev-Erba and T0901317
Earlier studies have shown that the nuclear receptor,
Rev-Erba, which also binds ROREs, can compete with
RORs for RORE binding (22,23,37,54). Figure 3A shows
that co-expression of Rev-Erba repressed the activation
of the Npas2 promoter by either RORa or RORg in a
dose-dependent manner. Moreover, expression of Rev-
Erba in Huh-7 cells repressed the endogenous activation
of the Npas2(–1534/+81) promoter (Figure 3B).
Mutation of RORE1/2 abolished this repression
indicating that this repression was mediated through
these ROREs. These observations are consistent with
the hypothesis that Rev-Erba functions as a repressor
of Npas2 expression and competes with RORs for
RORE binding. Recently, T0901317 was identiﬁed as
Nucleic Acids Research, 2011,Vol.39, No. 11 4773an inverse agonist of RORa and RORg (7). It was
therefore of interest to examine the effect of T0901317
on the expression of Npas2 induction. As shown in
Figure 3C, T0901317 was able to repress the activation
of the Npas2 promoter by RORg and RORa in Huh-7
cells.
Recruitment of RORs to the Npas2 promoter
To determine whether RORg was recruited to the ROREs
in the Npas2(–1534/+81) promoter in vivo, ChIP-qPCR
analysis was carried out using liver isolated from WT
and ROR knockout mice. Tissues were collected at
CT22, a time close to the peak expression of ROR  and
Npas2 mRNAs, and at CT10, a time at which both ROR 
and Npas2 mRNAs are expressed at their lowest level. On
this basis, one would expect higher recruitment of RORg
to the Npas2 promoter at CT22 than at CT10. The data in
Figure 4A conﬁrmed that RORg was more efﬁciently re-
cruited to the 1380 region of the Npas2 promoter in WT
liver collected at CT22 compared with the liver collected at
CT10. Primers targeting a region within the Gapdh gene
were used as negative control and did not show any
speciﬁc recruitment of RORg. As expected, at CT22, the
level of RORg associated with the Npas2 promoter in WT
liver was signiﬁcantly higher than in ROR 
/ liver, while
RORg was not recruited to a distal, non RORE-
containing region of the Npas2 gene. Although the loss
of RORa had only a small effect on Npas2 expression,
ChIP analysis indicated that RORa was associated with
the Npas2 promoter.
Npas2 activation and repression by RORs and Rev-Erba,
respectively, in Hepa1-6 cells
To obtain further evidence for the involvement of RORa/g
and Rev-Erba in the regulation of Npas2, we established
murinehepatomaHepa1-6celllinesstablyexpressingFlag-
taggedRORa, RORgorRev-Erba.Immunocytochemistry
using anti-Flag M2 antibody showed that these receptors
were expressed in these cells and localized to the nucleus
(data not shown). Figure 5A shows that Npas2 expression
was dramatically inducedin Hepa1-6 cells expressing either
RORa or RORg. In contrast, Rev-Erba overexpression
signiﬁcantly downregulated the expression of Npas2.
To analyze the recruitment of RORa, RORg and
Rev-Erba to the ROREs within the Npas2(–1534/+81)
promoter, we performed ChIP assay using the Hepa1-6
stable cell lines and an anti-Flag M2 antibody
(Figure 5B). Our data showed that all three receptors
were recruited to the 1380 region of the Npas2
promoter, consistent with the conclusion that Npas2 is
directly regulated by RORs and Rev-Erba.
Activation of the Npas2 promoter in relation to changes in
DNA accessibility and histone H3K9 acetylation
The FAIRE assay has been used to detect active regula-
tory regions (50) and although the roles of histone
Figure 2. Regulation of Npas2 expression by ROR is mediated through ROREs. (A) Schematic of the location of the RORE1 and RORE2 in the
proximal Npas2 promoter region. The bold and underlined sequences of these ROREs are conserved between the human and mouse genomes. The
numbers refer to the distance to the transcription start site. (B and C) RORs were able to effectively activate the (–1534/+81) Npas2 proximal
promoter in Huh-7 (B) and HEK293T cells (C). Cells were co-transfected with the indicated p3xFlag–CMV10–ROR expression vector, pCMV-b-Gal
and a pGL4.10 reporter plasmid driven by either the WT Npas2(–1534/+81) promoter or the promoter in which RORE1, RORE2 or both were
mutated (RORE1m, RORE2m and RORE1m2m, respectively). About 24h later the relative luciferase reporter activities were determined as
described in ‘Materials and Methods’ section. Data present mean±SEM.
4774 Nucleic Acids Research, 2011,Vol.39, No. 11acetylation, including H3K9Ac, are far from being
understood levels of acetylation correlate positively
with actively transcribed genes (55). To study the role
of chromatin modulation in Npas2 regulation, we ﬁrst
examined the FAIRE and the H3K9Ac signals within
the proximal Npas2 promoter region in DNA samples
from liver isolated at CT10 and CT22. As shown in
Figure 6, the FAIRE and H3K9Ac signals were
markedly increased in DNA samples from liver isolated
at CT22, a time at which Npas2 is most highly expressed,
compared with that of CT10. These results are consistent
with the concept that at CT22 this region of the Npas2
promoter is accessible and associated with functionally
active enhancers. Loss of either RORa or RORg expres-
sion led to a reduction in FAIRE signal and H3K9
acetylation at CT22 suggesting that ROR binding
promotes open chromatin structure at the site of the
Npas2 promoter.
Figure 3. Rev-Erba and the ROR-inverse agonist T0901317 inhibited ROR-induced activation of the Npas2(–1534/+81) promoter. (A) Rev-Erba
expression represses the activation of the Npas2 promoter by RORa and RORg, Huh-7 cells were transfected with p3xFlag-CMV10-RORg or
p3xFlag-CMV10-RORa, pGL4.10-Npas2(–1534/+81) and increasing concentrations of p3xFlag-CMV10-Rev-Erba and 24h later were assayed for
reporter activity. (B) The downregulation of basal Npas2 promoter activity by Rev-Erba was abrogated by mutations in the ROREs. Huh-7 cells
were transfected with p3xFlag-CMV10-Rev-Erba and pGL4.10 driven by the WT Npas2(–1534/+81) promoter or the promoter with the indicated
RORE mutations. About 24h later cells were assayed for reporter activity. (C) The inverse agonist, T0901317, represses the activation of the Npas2
promoter by both RORg and RORa in Huh-7 cells. Data present mean±SEM.
Figure 4. RORg and RORa are recruited to the Npas2 promoter. (A) Circadian time-dependent recruitment of RORg to the Npas2 promoter. ChIP
analysis was performed using an anti-RORg antibody and liver tissues (n=4) isolated from WT and ROR 
/ mice at CT10 (low expression of
RORg) and CT22 (high expression of RORg). Ampliﬁcation of the Gapdh gene was used as a negative control. Data present mean±SEM,
***P<0.001 by ANOVA. (B) ChIP analysis was performed with anti-ROR antibodies using liver tissues (n=4) isolated from WT, ROR 
sg/sg
and ROR 
/ mice at CT22. QPCR ampliﬁcation of a non RORE-containing distal site of the Npas2 gene was used as a negative control. Data
present mean±SEM, **P<0.01, ***P<0.001.
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Because of the observations that the expression of Npas2
was most signiﬁcantly affected in BAT of ROR 
/ mice
(Figure 1C) and that ROR  is highly expressed in BAT
compared with WAT and liver (Figure 7A), we were inter-
ested in exploring the relationship between the expression
of RORs and Npas2, and BAT differentiation and
function. Analysis of ROR  and Npas2 expression
showed that both were induced about 80- and 50-fold,
respectively, during differentiation of primary brown
preadipocytes (Figure 7B and C). In contrast to RORg,
Npas2 expression was repressed at later stages of differen-
tiation. The induction of Npas2 mRNA expression was
greatly reduced during differentiation of brown
preadipocytes isolated from ROR 
/ mice. However,
the expression of the adipocyte marker genes, Glut4 and
Fabp4, was at most time points not signiﬁcantly different
between WT and ROR 
/ adipocytes (Figure 7D and E)
indicating that the downregulation of Npas2 in ROR 
/
brown adipocytes was rather speciﬁc. BAT plays an im-
portant role in heat generation and a number of genes,
including Mfsd2a and Dio2, are greatly induced during
cold-induced thermogenesis (49,56). Figure 7F shows
that the level of Npas2 mRNA in the BAT was increased
about 7-fold during cold-induced thermogenesis and that
this induction was inhibited by 90% in BAT of ROR 
/
mice. Loss of RORg also repressed the induction of Dio2
and Mfsd2a during cold-induced thermogenesis. These
data suggest that, in addition to its circadian regulation
of Npas2, RORg plays a critical role in the regulation of
Npas2 expression during BAT differentiation and
cold-induced thermogenesis.
To study the role of RORg in the regulation of Npas2
in brown adipocytes further, we examined its expression
in immortalized brown preadipocyte cell lines stably
Figure 5. Overexpression of RORa/g or Rev-Erba in Hepa1-6 cells,
respectively, induced or repressed Npas2 activation. (A) Npas2 gene
expression was examined by QPCR analysis in Hepa1-6 cells (n=5)
stably expressing empty vector, Flag-RORa, Flag-RORg or Flag-Rev-
Erba. The expression of Npas2 in Hepa1-6(Empty) was normalized to
1. Data present mean±SEM, ***P<0.001 by ANOVA. (B) RORs
and Rev-Erba were recruited to the Npas2 promoter in Hepa1-6
cells. ChIP analysis was performed with the Hepa1-6 stable cell lines
and anti-Flag M2 antibody. Hepa1-6(Empty) served as a negative
control. Data present mean±SEM, ***P<0.001.
Figure 6. Activation of the Npas2 promoter in relation to changes in
DNA accessibility and histone H3K9 acetylation. (A) Accessibility to
Npas2(RORE1,2), as assessed by FAIRE-QPCR analysis, correlates
with Npas2 promoter activation. FAIRE-QPCR at Npas2(RORE1,2)
and at distal downstream site of the Npas2 gene was performed using
DNA samples isolated from liver of WT, ROR 
sg/sg and ROR 
/ mice
at CT10 and CT22. (B) Activation of the Npas2 promoter correlates
with H3K9 acetylation. ChIP-QPCR was performed at the proximal
Npas2 promoter (Npas2 –896/–813) and the distal site using
anti-H3K9Ac antibody and ChIPed-DNA samples isolated from liver
of WT, ROR 
sg/sg and ROR 
/ mice at CT10 and CT22. Data present
mean±SEM, *P<0.05, ***P<0.001.
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RORg(E502Q), referred to as BAT(E), BAT(RORg) and
BAT(RORgE502Q). As shown in Figure 8A, Npas2 was
induced at 6- to 7-fold higher levels during differentiation
of BAT(RORg) cells compared with BAT(E) cells. In
contrast, Npas2 was not elevated in BAT(RORgE502Q)
cells expressing an RORg mutant lacking transactivation
function. Treatment of BAT(RORg) cells with the inverse
agonist, T0901317, signiﬁcantly reduced the induction of
Npas2 mRNA (Figure 8A).
ChIP analysis with anti-Flag M2 antibody and
BAT(RORg) or BAT(E) cells showed strong recruitment
of Flag–RORg to the RORE-containing region of the
Npas2(–1534/+81) promoter (Figure 8B). These data
support our conclusion that RORg is recruited to the
Npas2(–1534/+81) promoter. The inverse agonist,
T0901317, did not signiﬁcantly inﬂuence the recruitment
of RORg to the Npas2 promoter suggesting that
T0901317-bound RORg was still recruited to ROREs
within the Npas2 promoter.
DISCUSSION
In this study, we provide evidence that RORs, RORg in
particular, are important regulators of Npas2 expression.
In WT mice, Npas2 displayed a strong oscillatory expres-
sion pattern in several tissues, including the kidney, liver
and BAT, with peak expression at CT20–CT24/0
(Figure 1) (24,51). Although the rhythmicity of Npas2
expression in these tissues was maintained in ROR 
/
mice, the peak level of Npas2 mRNA expression was sig-
niﬁcantly reduced. Except for the kidney, loss of RORa
had relatively little effect on Npas2 expression in the
tissues analyzed despite its recruitment to the Npas2
promoter. That loss of RORa has little effect on Npas2
expression might be related to weak RORa activity and
involve low levels of RORa protein bound relatively to
RORg or posttranslational modiﬁcations of RORa.
Additional evidence that RORs regulate Npas2 expression
was provided by data showing that overexpression of
either RORa or RORg in murine hepatoma Hepa1-6
cells greatly induced the expression of Npas2 mRNA
(Figure 5A).
We previously reported a certain degree of functional
redundancy between the regulation of gene expression by
RORa and RORg (16). For example, the hepatic expres-
sion of several Phases I and II metabolic genes was con-
siderably more affected in DKO than in single knockout
mice. Analysis of Npas2 expression in DKO mice
indicated no signiﬁcant functional redundancy between
Figure 7. The induction of Npas2 expression during brown adipocyte differentiation was regulated by RORg.( A) Comparison of ROR  and ROR 
expression in the WAT, BAT and several other tissues. ROR  and ROR  were highly expressed in the WAT and BAT, respectively. (B–E) ROR 
mRNA was highly induced during brown adipocyte differentiation. Primary cultures of BAT preadipocytes obtained from WT and ROR 
/ mice
were induced to differentiate as described in ‘Materials and Methods’ section. RNA was isolated at the times indicated and the expression of ROR ,
Npas2 and BAT differentiation markers, such as Glut4 and Fabp4, was examined by QPCR analysis. The data are an average of three isolates of
brown adipocytes from each WT and ROR 
/ BAT, respectively. e.g. preadipocytes in exponential phase. (F) The induction of Npas2 expression
during cold-induced thermogenesis was inhibited in the BAT of ROR 
/mice. WT and ROR 
/ mice (n=5) were placed at 4C for 4h before
BAT was collected for analysis at CT18. Data present mean±SEM, **P<0.01, ***P<0.001 by ANOVA.
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consistent with our conclusion that in these tissues Npas2
expression is regulated selectively by RORg with a minor
role for RORa. In contrast to Npas2, the expression of
Clock was signiﬁcantly reduced in the liver and BAT of
DKO mice (Supplementary Figure S1I), while the expres-
sion was not changed in single knockout mice suggesting a
redundant function of RORa and RORg in regulating
Clock.
RORs can regulate gene transcription directly by
binding ROREs in the regulatory region of target genes
or through indirect mechanisms (1). The 1534-nt proximal
promoter region of the Npas2 gene contains three putative
ROREs (27). In this study, we demonstrate that Npas2 is a
direct ROR target gene and that its transcriptional acti-
vation involves the recruitment of RORs to RORE1 and
RORE2. This is supported by reporter gene analysis
showing that expression of either RORa and RORg
activated the Npas2(–1534/+81) proximal promoter.
Mutation of either RORE1 or RORE2 partially reduced
the Npas2 promoter activity, whereas mutation of both
ROREs almost totally abolished activation of the Luc
reporter suggesting that optimal Npas2 induction by
RORg requires both ROREs. In contrast to an earlier
report, mutations in RORE3 had little effect on ROR-
induced activation of the Npas2(–1534/+81) promoter
suggesting that it plays a minor role in the regulation of
Npas2 by RORs. We further demonstrated by ChIP
analysis that RORa and RORg were recruited to these
ROREs in the Npas2 promoter in WT liver, Hepa1-6
and BAT cells. As expected no signiﬁcant recruitment of
RORa or RORg was observed in ROR 
sg/sg or ROR 
/
liver, respectively. Our data further showed that the re-
cruitment of RORg was CT dependent. In contrast to
CT22, when RORg is expressed at a high level, RORg
was not found to be associated with the Npas2 promoter
at CT10, when RORg expression is low. Collectively, these
data suggest that the regulation of Npas2 transcription by
RORg occurs by a direct mechanism. Transcriptional
activation is associated with increased chromatin accessi-
bility, as determined by FAIRE, and histone acetylation,
including H3K9 acetylation (50,55). Our data showed that
the FAIRE signal and H3K9 acetylation are signiﬁcantly
increased at the Npas2 promoter in liver at CT22
compared with CT10 consistent with increased accessibil-
ity and the high level of transcriptional activity of the
Npas2 promoter at CT22. Loss of RORg signiﬁcantly
reduced the FAIRE signal and H3K9 acetylation at the
Npas2 proximal promoter consistent with a relationship
between RORg binding, open chromatin structure and
transcriptional activation of Npas2. Despite the fact that
loss of RORa has little effect on Npas2 expression in liver,
it also caused a reduction in the FAIRE signal and H3K9
acetylation suggesting a role for RORa plays a role in
chromatin remodeling in Npas2. This is consistent with
the ChIP analysis showing binding of RORa to the
Npas2 ROREs (Figure 4) (53). Further studies are
required to understand the role of RORa in Npas2 gene
regulation. Chromatin remodeling might occur prior to
and/or following ROR binding. The observation that
loss of RORs did not totally inhibit Npas2 expression
and reduced FAIRE signal and H3K9 acetylation by
about 50% suggests that other transcription factors are
involved in the positive regulation of Npas2 and chroma-
tin remodeling of the Npas2 promoter. Thus, at CT22
RORs may bind to this region when it is already quite
Figure 8. RORg-activated Npas2 gene expression in brown adipocytes
through a direct mechanism. (A) Npas2 expression was examined in
brown adipocyte cell lines, BAT(E), BAT(RORg) and
BAT(RORgE502Q) stably expressing empty vector, RORg or the
RORgE502Q mutant containing an inactive activation domain, respect-
ively. Expression of Npas2 was compared between brown preadipocytes
at the exponential phase (U) and at differentiation Day 5 (D) as
indicated. BAT(RORg) cells were also treated at Day 4 for 24h with
10mM of the inverse agonist T0901317. (B) ChIP analysis was per-
formed using anti-Flag M2 antibody, BAT(E) cells (E) and
BAT(RORg) cells (R) treated with or without T0901317 as described
under (A). BAT(E) cells and the distal region were used as a negative
controls. The experiment was performed in triplicate. Data present
mean±SEM, ***P<0.001 by ANOVA.
4778 Nucleic Acids Research, 2011,Vol.39, No. 11accessible through the activity of other transcription
factors. RORs through their recruitment of histone
acetyltransferases, such as CBP/p300, likely contribute
to the increased histone acetylation and chromatin
remodeling.
Recent studies have demonstrated that RORs function
as ligand-dependent transcription factors (5–8,58).
T0901317 functions as an inverse agonist for both
RORa and RORg and has been reported to effectively
inhibit RORa- and RORg-mediated induction of Th17
differentiation and IL-17 expression. In this study, we
demonstrate that T0901317 inhibited the activation of
the Npas2 promoter by RORa and RORg in hepatoma
Huh-7 cells as well as in brown adipocytes. ChIP analysis
showed that T0901317 did not signiﬁcantly affect the re-
cruitment of RORg to the ROREs in the Npas2 proximal
promoter. The recruitment of RORg to the Npas2
promoter in the presence of T0901317 indicates that
T0901317 does not affect the interaction of RORs with
these ROREs. The inhibition of transcription is likely
due to a T0901317-induced change in the conformation
of the ROR receptors that affects their interaction with
co-activators and subsequently their transcriptional
activity. This hypothesis is supported by a recent study
showing that T0901317 inhibits the interaction of RORs
with the co-activator SRC-1 (7).
The nuclear receptors, Rev-Erba and Rev-Erbb, have
been reported to act as transcriptional repressors (59).
Moreover, it is well-established that Rev-Erb receptors
bind response elements similar to RORE and can
compete with RORs for RORE binding (22,23,37,54). In
this study, we demonstrated that Rev-Erba can also
function as a repressor of Npas2 expression. In contrast
to the effects of RORa or RORg, overexpression of
Rev-Erba in Hepa1-6 cells caused a reduction in Npas2
mRNA level (Figure 5A). In addition, overexpression of
Rev-Erba inhibited the basal Npas2(–1534/+81) promoter
activity (Figure 3B). Mutation of either RORE1 or
RORE2, but not RORE3, reduced this inhibition, while
the double mutation totally abrogated the repression by
Rev-Erba, suggesting that the inhibitory effect of
Rev-Erba is mediated through these two ROREs. This
was supported by ChIP analysis showing recruitment of
Rev-Erba to the RORE-containing region of the Npas2
promoter (Figure 5B). Thus, as RORs, Rev-Erbs play a
critical role in the regulation of Npas2 expression through
recognition of the same ROREs in the Npas2 promoter. It
is likely that competition between RORs and Rev-Erba
for RORE1 and RORE2 is part of the mechanism that
regulates the oscillatory expression of Npas2. This is
corroborated by data showing that Rev-Erba effectively
antagonized the activation of the Npas2 promoter by
RORs (Figure 3A).
We were interested in relating the regulation of Npas2
by RORg and Rev-Erba to their rhythmic pattern of ex-
pression. The oscillatory expression pattern of Npas2 and
ROR  are in almost opposite phase compared with that of
Rev-Erb , while ROR  reaches a peak slightly earlier than
Npas2 (Figures 1 and 9) (16,20,24,51). The lowest level of
Rev-Erb  mRNA expression occurred at CT16–CT24
when Npas2 and ROR  are expressed at peak levels,
whereas at CT8–CT10 the peak level of Rev-Erb  expres-
sion coincides with the lowest level of ROR  and Npas2
expression. These patterns of expression are consistent
with the hypothesis that at CT8-10 downregulation of
RORg and induction of Rev-Erba may act cooperatively
in repressing Npas2 expression, while induction of RORg
and repression of Rev-Erba jointly promote Npas2 expres-
sion at CT16–24 (Figure 9). A recent study demonstrated
that loss of Bmal1 abrogates Rev-Erb  expression and as a
result alleviates the repression of ROR  expression by
Rev-Erba (24), while RORa has been demonstrated to
positively regulate Rev-Erb  (22,60,61). Thus, RORg
and Rev-Erba are part of a regulatory loop that regulates
the circadian pattern of expression of Npas2 (Figure 9).
The opposite phases of the circadian expression of these
receptors and their competition for RORE binding col-
lectively participate in the regulation of the oscillatory
pattern of Npas2 expression.
As its paralog Clock, Npas2 forms a heterodimeric
complex with Bmal1 and regulates gene transcription by
interacting with E-boxes in the regulatory region of target
genes (39). Clock and Npas2 have been reported to exhibit
overlapping roles in the regulation of the circadian clock
genes in the SCN and circadian-controlled genes in liver
Figure 9. Schematic presentation of the molecular mechanism for the
antagonistic regulation of Npas2 circadian expression by RORg and
Rev-Erba. (Lower panel) Oscillatory pattern of expression of Npas2,
ROR  and Rev-Erb  in liver. (Upper panel) RORg functions as a
positive regulator of Npas2 transcription in vivo and in cultured cells
by binding to two ROREs in its proximal promoter region. RORg is
efﬁciently recruited to these ROREs at CT18–CT24/0 when ROR  and
Npas2 are highly expressed. Rev-Erb , which peak expression occurs
around CT8 (37), represses Npas2 expression through competitive
binding to the same ROREs. Rev-Erba has also been reported to
repress ROR  expression, while RORg can activate Rev-Erb  expres-
sion. The reduced ROR  expression and increased Rev-Erb  expression
at CT8–10 might act synergistically to reduce Npas2 circadian expres-
sion, while the inverse occurs at CT16–24. Thus, RORg and Rev-Erba
are parts of a regulatory loop regulating each other and consequently
the circadian expression of Npas2. Because loss of RORs does not
totally block Npas2 expression, other transcription factors likely
regulate its transcription as well.
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epidemiologic studies have provided evidence for a role
of Npas2 in several other biological processes. SNPs in
Npas2 have been linked to increased risk of cancer,
unipolar major depression, metabolic syndrome and
hypertension (42–47). Npas2 has been implicated in the
regulation of the DNA damage response pathway and
several cell cycle and DNA repair genes suggesting a
role for Npas2 as a tumor suppressor (45,46). In this
study, we demonstrate that both ROR  and Npas2 are
induced during differentiation of preadipocytes into
brown fat adipocytes. In addition, we show that Npas2
expression is enhanced in BAT during cold-induced
thermogenesis, suggesting a regulatory role for Npas2 in
this physiological process. However, Npas2 expression
was strongly downregulated in ROR 
/ brown adipo-
cytes during differentiation and in BAT of ROR 
/
mice during cold-induced thermogenesis. In addition, we
showed that T0901317 was able to inhibit the induction of
Npas2 by RORg in the brown adipocytes. Collectively,
these data support the conclusion that RORg functions
as a transcriptional activator of Npas2 in BAT.
Although our study suggests a role for Npas2 in thermo-
genesis, future studies are required to determine the
precise function of Npas2 and RORg in BAT cells.
Taken the role of Rev-Erbs, RORs and BAT in metabolic
syndrome, these data are of interest in the light of reports
showing that Npas2 gene variants have been linked to
increased risk of metabolic syndrome (16,17,22,43,62).
Our study shows that RORg regulates Npas2 expression
in vivo. Loss of RORg had little effect on the rhythmicity,
but reduced the peak level of Npas2 expression. RORg
regulates the transcription of Npas2 by binding to two
ROREs in its proximal promoter region and enhances
the accessibility to the proximal Npas2 promoter
enhancer region. The activation of Npas2 promoter by
RORs is repressed by co-expression with Rev-Erba or
addition of the inverse agonist T0901317. These observa-
tions suggest that RORs and Rev-Erba may be implicated
in the modulation of Npas2-controlled physiological
processes and Npas2-linked pathologies, including circa-
dian behavior disorders, metabolic syndrome and tumori-
genesis. Thus, changes in the level of the physiological
ligands of RORs and Rev-Erba may play an important
role in the development of these pathologies. In addition,
because RORs function as ligand-dependent transcription
factors, increased Npas2 expression by ROR agonists may
provide a novel therapeutic approach for disease in which
Npas2 has been implicated, including metabolic
syndrome, hypertension and depression.
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